Financhill
Sell
29

MNRO Quote, Financials, Valuation and Earnings

Last price:
$14.46
Seasonality move :
2.57%
Day range:
$14.09 - $15.61
52-week range:
$14.09 - $31.84
Dividend yield:
7.74%
P/E ratio:
22.61x
P/S ratio:
0.37x
P/B ratio:
0.67x
Volume:
2.6M
Avg. volume:
958.6K
1-year change:
-54.12%
Market cap:
$433.4M
Revenue:
$1.3B
EPS (TTM):
$0.64

Earnings Data

Next earnings date for MNRO
May 23
2025
Most recent earnings per share
$0.15
Missed by $0.15
(Jan 29/2025)
Consensus Estimate
$0.30
(Jan 29/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MNRO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $296.5M -- -- $0.18 --
05/23/2025 Q1 $288.6M -- -- $0.03 --
01/29/2025 Q4 $311.1M $305.8M $0.15 $0.30 -$0.15
10/30/2024 Q3 $300.1M $301.4M $0.18 $0.26 -$0.08
07/31/2024 Q2 $293.6M $293.2M $0.19 -- --
05/23/2024 Q1 $320.2M $310.1M $0.12 $0.30 -$0.18
01/24/2024 Q4 $324.8M $317.7M $0.38 $0.39 -$0.01
10/25/2023 Q3 -- -- $0.40 $0.40 $0.00
07/26/2023 Q2 -- -- $0.28 $0.38 -$0.10
05/18/2023 Q1 -- -- $0.01 $0.32 -$0.31
01/25/2023 Q4 -- -- $0.41 $0.43 -$0.02
10/26/2022 Q3 -- -- $0.40 $0.45 -$0.05
07/27/2022 Q2 -- -- $0.37 $0.36 $0.01
05/19/2022 Q1 -- -- $0.25 $0.46 -$0.21
01/26/2022 Q4 -- -- $0.48 $0.52 -$0.04
10/27/2021 Q3 -- -- $0.62 $0.55 $0.07
07/28/2021 Q2 -- -- $0.46 $0.52 -$0.06
05/20/2021 Q1 -- -- $0.35 $0.29 $0.06
01/27/2021 Q4 -- -- $0.20 $0.37 -$0.17
10/28/2020 Q3 -- -- $0.38 $0.29 $0.09
07/29/2020 Q2 -- -- $0.09 -$0.22 $0.31
05/28/2020 Q1 -- -- -$0.12 $0.21 -$0.33
01/30/2020 Q4 -- -- $0.56 $0.61 -$0.05
10/24/2019 Q3 -- -- $0.60 $0.71 -$0.11
07/25/2019 Q2 -- -- $0.68 $0.66 $0.02
05/21/2019 Q1 -- -- $0.51 $0.51 --
01/31/2019 Q4 -- -- $0.61 $0.60 $0.02
10/25/2018 Q3 -- -- $0.67 $0.65 $0.02
07/26/2018 Q2 -- -- $0.64 $0.66 -$0.02
05/21/2018 Q1 -- -- $0.50 $0.50 -$0.00
01/30/2018 Q4 -- -- $0.50 $0.51 -$0.01
10/24/2017 Q3 -- -- $0.55 $0.54 $0.01
07/20/2017 Q2 -- -- $0.53 $0.54 -$0.01
05/18/2017 Q1 -- -- $0.29 $0.32 -$0.03
02/01/2017 Q4 -- -- $0.53 $0.52 $0.01
10/20/2016 Q3 -- -- $0.53 $0.56 -$0.03
07/28/2016 Q2 -- -- $0.50 $0.49 $0.01
05/19/2016 Q1 -- -- $0.42 $0.43 -$0.01
01/26/2016 Q4 -- -- $0.51 $0.51 --
10/22/2015 Q3 -- -- $0.57 $0.56 $0.01
07/23/2015 Q2 -- -- $0.57 $0.58 -$0.01

Monro Earnings Questions

  • How Much did Monro Generate in Revenue Last Quarter?

    Monro reported $305.8M worth of top line sales in its most recent quarter.

  • Did Monro Beat Earnings Last Quarter?

    Monro announced earnings per share of $0.15 which represents a miss of analyst forecast a $0.30 per share.

  • Is Monro Profitable?

    Monro reported $104.8M that represents $3.35 per share over the last quarter.

  • What is the Analyst Consensus for Monro EPS Next Year?

    Monro's earnings are forecast to decrease from $1.18 per share to $0.60 per share next year representing a decrease of -49.15%.

  • When is Monro's Earnings Date?

    Monro's next earnings date is May 23, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Is JHX Stock a Buy Sell or Hold?
Is JHX Stock a Buy Sell or Hold?

James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Buy
80
CORT alert for Apr 1

Corcept Therapeutics [CORT] is down 13.38% over the past day.

Sell
16
PCVX alert for Apr 1

Vaxcyte [PCVX] is down 4.1% over the past day.

Sell
47
RGC alert for Apr 1

Regencell Bioscience Holdings [RGC] is down 5.68% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock